News

The NWG is conducting a Survey on Regulatory Requirements and Research Needs for Liposome Products amongst stakeholders, including Regulatory Agencies and other non-Regulatory stakeholders. Answers

The Working Group on Identification of Medicinal Products (IDMP) has updated its Frequently Asked Questions (FAQ) document to address questions related to IDMP standards and help support their

The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its fifth meeting on the 28th of May 2020. Representatives from 25 IPRP Members and Observers joined

The fourth meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (MC) was held on the 20th and 21st of November 2019 in Singapore. Representatives from 25 IPRP

A focus topic of the IPRP MC meeting in Amsterdam, the Netherlands, on 2-3 June 2019, was reliance, the act by which one regulatory authority takes into account the work performed by another

The Working Group on Identification of Medicinal Products (IDMP) has published a Frequently Asked Questions (FAQ) document to address questions related to IDMP standards and help support their

The third meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (MC) was held on the 2nd and 3rd of June 2019 in Amsterdam, the Netherlands. A total of 22 IPRP

To complement the template developed by the BEWGG for Biopharmaceutics Classification System (BCS) Biowaivers Assessment Reports, a template for Biowaiver Assessment Report for Additional Strength(s)

IPRP Reflection Paper General Principles to Address the Nature and Duration of Follow-up for Subjects of Clinical Trials Using Cell Therapy Products   The Reflection Paper on “General

While maintaining its focus as a forum for regulators to share best practices and experiences, IPRP is also committed to engage with its external stakeholders where needed. The IPRP Stakeholder